Wuyou Xindong develops minimally invasive devices for treating cardiac conditions.
Established in 2021 and based in Shenzhen, China, Wuyou Xindong develops minimally invasive interventional devices for cardiac disease. Its products include automated cardiac bypass diagnostic devices, compliant balloons, and biodegradable blocking systems. In October 2025, it raised approximately CNY 100 million in Series A funding led by Taiping Innovation Investment Management, with Yangtze River Industry Fund participating. The funding will support product industrialization and commercialization.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Wuyou Xindong Medical Technology (Shenzhen)? This is my company